286 results on '"Meijers, J.C.M."'
Search Results
2. Lupus anticoagulant associates with thrombosis in patients with COVID‐19 admitted to intensive care units: A retrospective cohort study
3. Role of von Willebrand factor and ADAMTS‐13 in early brain injury after experimental subarachnoid hemorrhage
4. Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso‐occlusive crisis and steady state
5. Association between protein C levels and mortality in patients with advanced prostate, lung and pancreatic cancer
6. The influence of corticosteroids on hemostasis in healthy subjects
7. Structure‐function relationships in thrombin‐activatable fibrinolysis inhibitor
8. Selective modulation of thrombin‐activatable fibrinolysis inhibitor (TAFI) activation by thrombin or the thrombin‐thrombomodulin complex using TAFI‐derived peptides
9. Thrombin‐activatable fibrinolysis inhibitor influences disease severity in humans and mice with pneumococcal meningitis
10. In vivo increase in thrombin generation by four‐factor prothrombin complex concentrate in apixaban‐treated healthy volunteers
11. Lack of TAFI increases brain damage and microparticle generation after thrombolytic therapy in ischemic stroke
12. Development of a Hyperactive Primary Hemostatic System During Off-Pump Lung Transplantation Resulting From an Unbalance Between von Willebrand Factor and Its Cleaving Protease ADAMTS13
13. Fresh frozen plasma transfusion fails to influence the hemostatic balance in critically ill patients with a coagulopathy
14. A role for arginine‐12 in thrombin–thrombomodulin‐mediated activation of thrombin‐activatable fibrinolysis inhibitor
15. Endogenous protein C has a protective role during Gram‐negative pneumosepsis (melioidosis)
16. The hyperfibrinolytic state of mice with combined thrombin‐activatable fibrinolysis inhibitor (TAFI) and plasminogen activator inhibitor‐1 gene deficiency is critically dependent on TAFI deficiency
17. Intact thrombin generation and decreased fibrinolytic capacity in patients with acute liver injury or acute liver failure
18. Induction of anti‐β2‐glycoprotein I autoantibodies in mice by protein H of Streptococcus pyogenes
19. Plasminogen activator inhibitor type I contributes to protective immunity during experimental Gram‐negative sepsis (melioidosis)
20. Alterations in coagulation and fibrinolysis after levothyroxine exposure in healthy volunteers: a controlled randomized crossover study
21. β2‐Glycoprotein I: evolution, structure and function
22. High levels of protein C are determined by PROCR haplotype 3
23. Decreased active von Willebrand factor level owing to shear stress in aortic stenosis patients
24. Coagulation factor XI as a novel target for antithrombotic treatment
25. Thrombin‐activatable fibrinolysis inhibitor is degraded by Salmonella enterica and Yersinia pestis
26. Hyperglycemia: a prothrombotic factor?
27. Explanations for coagulation activation after air travel
28. Increased sperm count may account for high population frequency of factor V Leiden
29. Venous thrombosis is associated with hyperglycemia at diagnosis: a case–control study
30. The activation peptide of thrombin‐activatable fibrinolysis inhibitor: a role in activity and stability of the enzyme?
31. ApoAI‐phosphatidylcholine infusion neutralizes the atherothrombotic effects of C‐reactive protein in humans
32. Tumor necrosis factor-α inhibition protects against endotoxin-induced endothelial glycocalyx perturbation
33. Effect of the selective serotonin reuptake inhibitor paroxetine on platelet function is modified by a SLC6A4 serotonin transporter polymorphism
34. Perioperative hyperinsulinaemic normoglycaemic clamp causes hypolipidaemia after coronary artery surgery
35. Activation of coagulation with concurrent impairment of anticoagulant mechanisms correlates with a poor outcome in severe melioidosis
36. Development of sandwich‐type ELISAs for the quantification of rat and murine thrombin activatable fibrinolysis inhibitor in plasma
37. Tissue factor‐dependent blood coagulation is enhanced following delivery irrespective of the mode of delivery
38. Activation of coagulation system during air travel: a crossover study
39. Anticoagulant and anti‐inflammatory effects after peritoneal lavage with antithrombin in experimental polymicrobial peritonitis
40. Vagus nerve stimulation inhibits activation of coagulation and fibrinolysis during endotoxemia in rats
41. The differential association of conjugated equine estrogen and esterified estrogen with activated protein C resistance in postmenopausal women
42. Lupus anticoagulants and the risk of a first episode of deep venous thrombosis
43. Tumor growth and metastasis are not affected in thrombin‐activatable fibrinolysis inhibitor‐deficient mice
44. Recombinant nematode anticoagulant protein c2, an inhibitor of tissue factor/factor VIIa, attenuates coagulation and the interleukin‐10 response in human endotoxemia
45. Potential Role of Platelets in Endothelial Damage Observed During Treatment With Cisplatin, Gemcitabine, and the Angiogenesis Inhibitor SU5416
46. Factor XI promotes hemostasis in factor IX‐deficient mice
47. Recombinant factor VIIa reverses the in vitro and ex vivo anticoagulant and profibrinolytic effects of fondaparinux
48. Impaired healing of cutaneous wounds and colonic anastomoses in mice lacking thrombin-activatable fibrinolysis inhibitor
49. Procoagulant protein levels are differentially increased during human endotoxemia
50. Zika virus infection induces elevation of tissue factor production and apoptosis on human umbilical vein endothelial cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.